Abstract:Ganoderma lucidum is a precious fungus, particularly valued for its dual use as both medicine and food. Ganoderic acids (GAs), the distinctive triterpenoids found in the Ganoderma genus, exhibit a wide range of pharmacological activities. However, the limited resources of GAs restrict their clinic usage and drug discovery. In this review, we presented a comprehensive summary focusing on the diverse structures and pharmacological activity of GAs in G. lucidum . Additionally, we discussed the latest advancements in the elucidation of GA biosynthesis, as well as the progress in heterosynthesis and liquid fermentation methods aimed at further increasing GA production. Furthermore, we summarized the omics data, genetic transformation system, and cultivation techniques of G. lucidum , described as medicinal model fungi. The understanding of Ganoderic acids chemodiversity and biosynthesis in medicinal model fungi Ganoderma lucidum will provide important insights into the exploration and utilization of natural products in medicinal fungi.

What problem does this paper attempt to address?

The main problems that this paper attempts to solve are the chemical diversity, pharmacological activities and biosynthesis mechanism of ganoderic acids (GAs), a unique triterpenoid compound in Ganoderma lucidum. Specifically, the paper focuses on the following aspects: 1. **Chemical diversity and pharmacological activities**: The paper comprehensively summarizes the multiple structures of GAs and their extensive pharmacological activities, such as anti - cancer, anti - inflammatory, immunomodulatory, hypoglycemic, and hypolipidemic effects. These properties make GAs have great potential in drug development and clinical applications. 2. **Biosynthesis pathway**: The paper explores the biosynthesis pathway of GAs, especially the oxidative modification process from lanosterol to GAs. Although the upstream mevalonic acid (MVA) pathway has been relatively clear, there are still many unknowns in the downstream biotransformation process. The paper summarizes the currently discovered key enzymes, such as CYP5150L8, CYP512U6, CYP5139G1 and CYP512W2, which play important roles in the biosynthesis of GAs. 3. **Heterologous synthesis and liquid fermentation technology**: In order to increase the yield of GAs, the paper also discusses the methods of producing GAs through heterologous synthesis (such as expressing key enzymes in yeast) and liquid fermentation technology (such as submerged fermentation). These methods can significantly improve the yield and quality of GAs, thereby meeting market demands. 4. **Genomics and transcriptomics data**: The paper uses genomics and transcriptomics data to deeply explore the genetic background of G. lucidum, especially the genes related to secondary metabolite synthesis, transport and regulation. These data provide an important molecular basis for understanding the biosynthesis of GAs. In summary, this paper aims to comprehensively summarize the chemical diversity, pharmacological activities and biosynthesis mechanism of GAs, providing theoretical basis and technical support for future research and applications.

Chemodiversity, pharmacological activity, and biosynthesis of specialized metabolites from medicinal model fungi Ganoderma lucidum

Ganoderma Lucidum: an Emerging Medicinal Model Fungus for Study of the Biosynthesis of Natural Medicines

Ganoderma lucidum and its pharmaceutically active compounds

A Comprehensive Review on the Chemical Composition, Pharmacology and Clinical Applications of Ganoderma

Research Progress on the Biological Activity of Ganoderic Acids in Ganoderma lucidum over the Last Five Years

Ganoderma lucidum: A Potent Pharmacological Macrofungus

Therapeutic potential and nutritional significance of Ganoderma lucidum - a comprehensive review from 2010 to 2022

Transcriptome and metabolome analyses reveal transcription factors regulating ganoderic acid biosynthesis in Ganoderma lucidum development

Characteristics of the Genome, Transcriptome and Ganoderic Acid of the Medicinal Fungus Ganoderma lingzhi

A Review on the Sources, Structures, and Pharmacological Activities of Lucidenic Acids

Germplasm resources and secondary metabolism regulation in Reishi mushroom (Ganoderma lucidum)

A Review of Ganoderma lucidum Polysaccharide: Preparations, Structures, Physicochemical Properties and Application

Potentialities of Ganoderma lucidum extracts as functional ingredients in food formulation

Changes of Active Substances in Ganoderma lucidum during Different Growth Periods and Analysis of Their Molecular Mechanism

Deep Insight into the Ganoderma Lucidum by Comprehensive Analysis of Its Transcriptome

Recent Advances in the Preparation, Structure, and Biological Activities of β-Glucan from Ganoderma Species: A Review

The Biological Activity of Ganoderma lucidum on Neurodegenerative Diseases: The Interplay between Different Active Compounds and the Pathological Hallmarks

A Review of Chemical Composition and Bioactivity Studies of the Most Promising Species of Ganoderma spp.

Regulatory effect of Ganoderma lucidum and its active components on gut flora in diseases

Applied modern biotechnology for cultivation of Ganoderma and development of their products

Screening Immunoactive Compounds of Ganoderma lucidum Spores by Mass Spectrometry Molecular Networking Combined With in vivo Zebrafish Assays